UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

Leukemia, 2017-12, Vol.31 (12), p.2833-2837

2017

Volltextzugriff (PDF)

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group

Annals of oncology, 2013-06, Vol.24 (6), p.1580-1587

2013

Volltextzugriff (PDF)

Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study – AIO SUP-0108

European journal of cancer (1990), 2016-08, Vol.63, p.127-134

2016

Volltextzugriff (PDF)

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.56-58

2023

Volltextzugriff (PDF)

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

British journal of cancer, 2011-03, Vol.104 (7), p.1071-1078

2011

Volltextzugriff (PDF)

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.38-40

2019

Volltextzugriff (PDF)

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines

Annals of oncology, 2008-05, Vol.19 (5), p.871-876

2008

Volltextzugriff (PDF)

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

The lancet oncology, 2015-08, Vol.16 (8), p.979-989

2015

Volltextzugriff (PDF)

Knowledge and experience of palliative medicine among general practitioners in Germany

Deutsche medizinische Wochenschrift (1946), 2007-12, Vol.132 (49), p.2620

2007

Volltextzugriff (PDF)

Palliativmedizinische Erfahrungen deutscher Hausärzte

Deutsche medizinische Wochenschrift, 2007-12, Vol.132 (49), p.2620-2623

2007

Volltextzugriff (PDF)

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Annals of oncology, 2018-01, Vol.29 (1), p.178-185

2018

Volltextzugriff (PDF)

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Clinical lymphoma, myeloma and leukemia, 2018-10, Vol.18 (10), p.e401-e419

2018

Volltextzugriff (PDF)

Palliativmedizinische Erfahrungen deutscher Hausärzte

Deutsche medizinische Wochenschrift, 2007-12, Vol.132 (49), p.2620-2623

2007

Volltextzugriff (PDF)

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Annals of oncology, 2013-09, Vol.24 (9), p.2342-2349

2013

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.56

2023

Volltextzugriff (PDF)

9210 Bendamustine vs. fludarabine as second-line treatment in chronic lymphocytic leukemia

European journal of cancer supplements, 2009, Vol.7 (2), p.563-563

2009

Volltextzugriff (PDF)

Ambulante palliativmedizinischeBetreuung von Tumorpatienten

Best practice onkologie, 2007-08, Vol.2 (4), p.46-54

2007

Volltextzugriff (PDF)

Ambulante palliativmedizinische Betreuung von Tumorpatienten: Aus dem Blickwinkel des Klinikers und des niedergelassenen Onkologen

Best practice onkologie, 2007-08, Vol.2 (4), p.46-54

2007

Volltextzugriff (PDF)

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study

Clinical epidemiology, 2015-01, Vol.7 (default), p.295-303

2015

Volltextzugriff (PDF)

1487PDINTRAPERITONEAL BEVACIZUMAB (BEV) FOR CONTROL OF MALIGNANT ASCITES DUE TO ADVANCED-STAGE GASTROINTESTINAL CANCERS (GI): A MULTICENTER DOUBLE-BLIND, PLACEBO (PL)-CONTROLLED, RANDOMIZED PHASE II STUDY. AIO SUP-0108

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv520-iv520

2014

Volltextzugriff (PDF)

Intraperitoneal Bevacizumab (Bev) for Control of Malignant Ascites Due to Advanced-Stage Gastrointestinal Cancers (Gi): a Multicenter Double-Blind, Placebo (Pl)-Controlled, Randomized Phase Ii Study. Aio Sup-0108

Annals of oncology, 2014-09, Vol.25, p.iv520

2014

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Aktive Filter

ThemaChild

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Englisch
(175)
Deutsch
(54)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Humans
(58)
Life Sciences & Biomedicine
(58)
Female
(32)
Biological And Medical Sciences
(30)
Male
(29)
Physical Sciences
(29)
Physics
(24)
Adult
(22)
Medical Sciences
(21)
Middle Aged
(20)
Aged
(18)
Oncology
(18)
Animals
(14)
Energy Range
(14)
Physics, Multidisciplinary
(13)
Treatment Outcome
(11)
Aged, 80 And Over
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Measured Values
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group

Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study – AIO SUP-0108

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

Knowledge and experience of palliative medicine among general practitioners in Germany

Palliativmedizinische Erfahrungen deutscher Hausärzte

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Palliativmedizinische Erfahrungen deutscher Hausärzte

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

9210 Bendamustine vs. fludarabine as second-line treatment in chronic lymphocytic leukemia

Ambulante palliativmedizinischeBetreuung von Tumorpatienten

Ambulante palliativmedizinische Betreuung von Tumorpatienten: Aus dem Blickwinkel des Klinikers und des niedergelassenen Onkologen

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study

1487PDINTRAPERITONEAL BEVACIZUMAB (BEV) FOR CONTROL OF MALIGNANT ASCITES DUE TO ADVANCED-STAGE GASTROINTESTINAL CANCERS (GI): A MULTICENTER DOUBLE-BLIND, PLACEBO (PL)-CONTROLLED, RANDOMIZED PHASE II STUDY. AIO SUP-0108

Intraperitoneal Bevacizumab (Bev) for Control of Malignant Ascites Due to Advanced-Stage Gastrointestinal Cancers (Gi): a Multicenter Double-Blind, Placebo (Pl)-Controlled, Randomized Phase Ii Study. Aio Sup-0108

Updated Os Analysis, Multivariate and Qtwist Analysis of a Randomized Sequential Open-Label Study (Switch) to Evaluate Efficacy and Safety of Sorafenib (So) / Sunitinib (Su) Versus Su/So in the Treatment of Metastatic Renal Cell Cancer (Mrcc)

Aktive Filter

Suchergebnisse filtern